CoChat

Promoter hypermethylation of tumor suppressor and tumor‐related genes in non‐small cell lung cancers

Open access
Yanagawa, Naoki, Tamura, Gen, Oizumi, Hiroyuki, Takahashi, Nobumasa, Shimazaki, Yasuhisa, Motoyama, Teiichi · 2003 · Cancer Science
Cited by 136

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Aberrant methylation of promoter CpG islands is known to be a major inactivation mechanism of tumor suppressor and tumor‐related genes. To determine the clinicopathological significance of gene promoter methylation in non‐small cell lung cancer (NSCLC), we examined the promoter methylation status of the APC, DAP‐kinase, E‐cadherin, GSTP1, hMLH1, p16, RASSF1A and RUNX3 genes in 75 NSCLCs and corresponding non‐neoplastic lung tissues by methylation‐specific PCR (MSP). The frequencies of methylation in NSCLCs and corresponding non‐neoplastic lung tissues were: 37% (28 of 75) and 48% (36 of 75) for APC, 28% (21 of 75) and 13% (10 of 75) for DAP‐kinase, 29% (22 of 75) and 15% (11 of 75) for E‐cadherin, 1% (1 of 75) and 0% (0 of 75) for GSTP1, 7% (5 of 75) and 0% (0 of 75) for hMLH1, 31% (23 of 75) and 0% (0 of 75) for p16, 43% (32 of 75) and 4% (3 of 75) for RASSF1A, and 20% (15 of 75) and 3% (2 of 75) for RUNX3, respectively. Methylation of p16 was more frequent in squamous cell carcinomas than in adenocarcinomas (P<0.05), and was associated with tobacco smoking (P<0.05). On the contrary, methylation of APC and RUNX3 was more frequent in adenocarcinomas than in squamous cell carcinomas (P<0.05). Thus, a different set of genes is thought to undergo promoter methylation, which leads to the development of different histologies. In addition, methylation of p16, RASSF1A and RUNX3 was mostly cancer‐specific (P<0.05), and may be utilized as a molecular diagnostic marker of NSCLCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1349-7006.2003.tb01487.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 136

Metadata

Authors
Yanagawa, N., Tamura, G., Oizumi, H., Takahashi, N., Shimazaki, Y., & Motoyama, T.
Venue
Cancer Science
Publisher
Wiley
Published
2003-07
Volume
94
Issue
7
Pages
589-592
ISSN
  • 1347-9032 (ISSN-L)
  • 1349-7006
OpenAlex
W1989585142
Cited by
136
References
2
FWCI
3.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Promoter hypermethylation of tumor suppressor and tumor‐related genes in non‐small cell lung cancers. https://app.cochat.ai/papers/10.1111/j.1349-7006.2003.tb01487.x
The paper
Yanagawa, N., Tamura, G., Oizumi, H., Takahashi, N., Shimazaki, Y., & Motoyama, T. (2003). Promoter hypermethylation of tumor suppressor and tumor‐related genes in non‐small cell lung cancers. Cancer Science. https://doi.org/10.1111/j.1349-7006.2003.tb01487.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.